SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Barry O.)
 

Search: WFRF:(Barry O.) > (2015-2019) > Which advanced hear...

  • Gernhofer, Yan K.University of California, San Diego (author)

Which advanced heart failure therapy strategy is optimal for patients over 60 years old?

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • 2019
  • 8 s.

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:327b4079-be16-417d-96f7-b2c4099d6127
  • https://lup.lub.lu.se/record/327b4079-be16-417d-96f7-b2c4099d6127URI
  • https://doi.org/10.23736/S0021-9509.18.10593-3DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • BACKGROUND: The optimal advanced heart failure (HF) therapy strategy for patients aged 60 or older with end-stage HF refractory to optimal medical therapy remains uncertain. This study compares outcomes of three advanced HF therapy strategies in this patient population. METHODS: A single-center retrospective study was conducted in 95 patients aged 60-73 years who had undergone isolated heart transplantation (HTx) or continuous flow left ventricular assist device (LVAD) implantation from 2010 to 2017. Patients were stratified into three cohorts by strategy; HTx-only (N.=25), LVAD-to-HTx (N.=29), and LVAD-only (N.=41). Primary end point was 2-year overall survival. Secondary end points included incidence of post-operative adverse events, freedom from first readmission at 1 year, and percentage of days spent in hospital following advanced HF therapy. RESULTS: Two-year survival was 91% in HTx-only patients, 88% in LVAD-to-HTx patients, and 49% in LVAD-only patients (P=0.0008). No significant difference in post-transplant survival was found between patients with or without LVAD-related adverse events preceding transplantation (P=0.42). One-year freedom from first readmission was 38.3% in HTx-only patients, 17.2% in LVAD-to-HTx patients and 7.3% in LVAD-only patients (P=0.0028). Patients in LVAD-to-HTx cohort had higher incidences of gastrointestinal bleeding (38% vs. 3%; P<0.01), major bleeding (28% vs. 3%; P=0.02), and right heart failure (69% vs. 31%; P<0.01) during post-LVAD period compared with post-HTx period. Their percentage of days spent in hospital during post-LVAD period was significantly higher than post-HTx period (7.9% vs. 1.2%; P<0.001). CONCLUSIONS: Our experience with patients over 60 years old undergoing advanced therapy suggests that HTx-only and LVAD-to-HTx strategies had superior medium-term survival than LVAD-only strategy. LVAD-to-HTx strategy is effective in reducing incidence of adverse events and percentage of hospitalized days in this specific patient population.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Braun, Oscar O.Lund University,Lunds universitet,Heart Failure and Mechanical Support,Forskargrupper vid Lunds universitet,Lund University Research Groups,Skåne University Hospital(Swepub:lu)kard-oos (author)
  • Brambatti, MichelaUniversity of California, San Diego (author)
  • Bui, Quan M.University of California, San Diego (author)
  • Silva Enciso, JorgeUniversity of California, San Diego (author)
  • Greenberg, Barry H.University of California, San Diego (author)
  • Adler, EricUniversity of California, San Diego (author)
  • Pretorius, VictorUniversity of California, San Diego (author)
  • University of California, San DiegoHeart Failure and Mechanical Support (creator_code:org_t)

Related titles

  • In:The Journal of cardiovascular surgery60:2, s. 251-2580021-9509

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view